Kelfred Holdings Limited (1134.HK) Stock Competitors & Peer Comparison

1134.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1134.HK stands at 170M. In comparison, 2276.HK has a market cap of 20.7B. Regarding current trading prices, 1134.HK is priced at HK$0.34, while 2276.HK trades at HK$41.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1134.HK currently has a P/E ratio of -11.33, whereas 2276.HK's P/E ratio is 30.47. In terms of profitability, 1134.HK's ROE is -0.10%, compared to 2276.HK's ROE of +0.21%. Regarding short-term risk, 1134.HK is less volatile compared to 2276.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1134.HK.Check 2276.HK's competition here

1134.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1134.HK stands at 170M. In comparison, 1066.HK has a market cap of 15.6B. Regarding current trading prices, 1134.HK is priced at HK$0.34, while 1066.HK trades at HK$3.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1134.HK currently has a P/E ratio of -11.33, whereas 1066.HK's P/E ratio is 8.77. In terms of profitability, 1134.HK's ROE is -0.10%, compared to 1066.HK's ROE of +0.07%. Regarding short-term risk, 1134.HK is less volatile compared to 1066.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1134.HK.Check 1066.HK's competition here

1134.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1134.HK stands at 170M. In comparison, 6699.HK has a market cap of 12.2B. Regarding current trading prices, 1134.HK is priced at HK$0.34, while 6699.HK trades at HK$72.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1134.HK currently has a P/E ratio of -11.33, whereas 6699.HK's P/E ratio is 53.06. In terms of profitability, 1134.HK's ROE is -0.10%, compared to 6699.HK's ROE of +0.05%. Regarding short-term risk, 1134.HK is more volatile compared to 6699.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1134.HK.Check 6699.HK's competition here

1134.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1134.HK stands at 170M. In comparison, 9997.HK has a market cap of 10.8B. Regarding current trading prices, 1134.HK is priced at HK$0.34, while 9997.HK trades at HK$9.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1134.HK currently has a P/E ratio of -11.33, whereas 9997.HK's P/E ratio is 17.69. In terms of profitability, 1134.HK's ROE is -0.10%, compared to 9997.HK's ROE of +0.21%. Regarding short-term risk, 1134.HK is more volatile compared to 9997.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1134.HK.Check 9997.HK's competition here

1134.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1134.HK stands at 170M. In comparison, 3600.HK has a market cap of 5.4B. Regarding current trading prices, 1134.HK is priced at HK$0.34, while 3600.HK trades at HK$6.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1134.HK currently has a P/E ratio of -11.33, whereas 3600.HK's P/E ratio is 9.05. In terms of profitability, 1134.HK's ROE is -0.10%, compared to 3600.HK's ROE of +0.19%. Regarding short-term risk, 1134.HK is less volatile compared to 3600.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1134.HK.Check 3600.HK's competition here

1134.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1134.HK stands at 170M. In comparison, 1501.HK has a market cap of 5.3B. Regarding current trading prices, 1134.HK is priced at HK$0.34, while 1501.HK trades at HK$32.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1134.HK currently has a P/E ratio of -11.33, whereas 1501.HK's P/E ratio is 22.16. In terms of profitability, 1134.HK's ROE is -0.10%, compared to 1501.HK's ROE of +0.11%. Regarding short-term risk, 1134.HK is more volatile compared to 1501.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1134.HK.Check 1501.HK's competition here

1134.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1134.HK stands at 170M. In comparison, 6929.HK has a market cap of 3.6B. Regarding current trading prices, 1134.HK is priced at HK$0.34, while 6929.HK trades at HK$4.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1134.HK currently has a P/E ratio of -11.33, whereas 6929.HK's P/E ratio is 10.80. In terms of profitability, 1134.HK's ROE is -0.10%, compared to 6929.HK's ROE of +0.10%. Regarding short-term risk, 1134.HK is less volatile compared to 6929.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1134.HK.Check 6929.HK's competition here

1134.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1134.HK stands at 170M. In comparison, 1358.HK has a market cap of 1.7B. Regarding current trading prices, 1134.HK is priced at HK$0.34, while 1358.HK trades at HK$1.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1134.HK currently has a P/E ratio of -11.33, whereas 1358.HK's P/E ratio is 16.86. In terms of profitability, 1134.HK's ROE is -0.10%, compared to 1358.HK's ROE of +0.02%. Regarding short-term risk, 1134.HK is more volatile compared to 1358.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1134.HK.Check 1358.HK's competition here

1134.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1134.HK stands at 170M. In comparison, 1120.HK has a market cap of 289.7M. Regarding current trading prices, 1134.HK is priced at HK$0.34, while 1120.HK trades at HK$0.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1134.HK currently has a P/E ratio of -11.33, whereas 1120.HK's P/E ratio is 15.00. In terms of profitability, 1134.HK's ROE is -0.10%, compared to 1120.HK's ROE of +0.04%. Regarding short-term risk, 1134.HK is less volatile compared to 1120.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1134.HK.Check 1120.HK's competition here

1134.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1134.HK stands at 170M. In comparison, 1942.HK has a market cap of 155.1M. Regarding current trading prices, 1134.HK is priced at HK$0.34, while 1942.HK trades at HK$0.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1134.HK currently has a P/E ratio of -11.33, whereas 1942.HK's P/E ratio is -1.41. In terms of profitability, 1134.HK's ROE is -0.10%, compared to 1942.HK's ROE of -0.10%. Regarding short-term risk, 1134.HK is less volatile compared to 1942.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1134.HK.Check 1942.HK's competition here

1134.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1134.HK stands at 170M. In comparison, 0907.HK has a market cap of 53.2M. Regarding current trading prices, 1134.HK is priced at HK$0.34, while 0907.HK trades at HK$0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1134.HK currently has a P/E ratio of -11.33, whereas 0907.HK's P/E ratio is -3.05. In terms of profitability, 1134.HK's ROE is -0.10%, compared to 0907.HK's ROE of +1.84%. Regarding short-term risk, 1134.HK is more volatile compared to 0907.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1134.HK.Check 0907.HK's competition here

1134.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1134.HK stands at 170M. In comparison, 0876.HK has a market cap of 7.9M. Regarding current trading prices, 1134.HK is priced at HK$0.34, while 0876.HK trades at HK$0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1134.HK currently has a P/E ratio of -11.33, whereas 0876.HK's P/E ratio is -7.80. In terms of profitability, 1134.HK's ROE is -0.10%, compared to 0876.HK's ROE of -0.11%. Regarding short-term risk, 1134.HK is more volatile compared to 0876.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1134.HK.Check 0876.HK's competition here